May 2017

LONDON, May 02, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 9 May, 2017 its second quarter financial results for the period ending 31 March, 2017. GW will also host a […]

Vitality Biopharma Inc (OTCMKTS:VBIO) is in two highly volatile industries- Cannabis and Biopharma. Cannabis related biopharma is a buzzword that has become an important industry term the investing world realizes will deliver revenues that have nothing to do with retail pot sales. Vitality Biopharma Inc (OTCMKTS:VBIO) is in the business of biopharma, and they released one of […]

The U.S. Food and Drug Administration (FDA) is aware that cannabis and cannabis-derived products are being used for a number of medical conditions, such as AIDS wasting syndrome, epilepsy, neuropathic pain, treatment of spasticity associated with multiple sclerosis, and cancer and chemotherapy-induced nausea. Despite this fact, the FDA has not yet approved a marketing application […]